HomeCompareNINTF vs JNJ

NINTF vs JNJ: Dividend Comparison 2026

NINTF yields 4.90% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NINTF wins by $952.00 in total portfolio value
10 years
NINTF
NINTF
● Live price
4.90%
Share price
$3.50
Annual div
$0.17
5Y div CAGR
-39%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.0K
Annual income
$3.72
Full NINTF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — NINTF vs JNJ

📍 NINTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNINTFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NINTF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NINTF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NINTF
Annual income on $10K today (after 15% tax)
$416.11/yr
After 10yr DRIP, annual income (after tax)
$3.16/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $700.45/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NINTF + JNJ for your $10,000?

NINTF: 50%JNJ: 50%
100% JNJ50/50100% NINTF
Portfolio after 10yr
$20.5K
Annual income
$415.75/yr
Blended yield
2.03%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

NINTF
No analyst data
Altman Z
0.4
Piotroski
5/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NINTF buys
0
JNJ buys
0
No recent congressional trades found for NINTF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNINTFJNJ
Forward yield4.90%3.36%
Annual dividend / share$0.17$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR-39%5.8%
Portfolio after 10y$21.0K$20.0K
Annual income after 10y$3.72$827.78
Total dividends collected$780.00$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: NINTF vs JNJ ($10,000, DRIP)

YearNINTF PortfolioNINTF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,999$298.62$10,676$355.77+$323.00NINTF
2$11,956$187.24$11,407$389.39+$549.00NINTF
3$12,909$116.04$12,198$426.53+$711.00NINTF
4$13,884$71.42$13,056$467.62+$828.00NINTF
5$14,899$43.79$13,987$513.12+$912.00NINTF
6$15,969$26.79$14,998$563.56+$971.00NINTF
7$17,103$16.37$16,098$619.52+$1.0KNINTF
8$18,311$10.00$17,295$681.69+$1.0KNINTF
9$19,598$6.10$18,599$750.82+$999.00NINTF
10$20,974$3.72$20,022$827.78+$952.00NINTF

NINTF vs JNJ: Complete Analysis 2026

NINTFStock

Ninety One Group operates as an independent global asset manager worldwide. It serves private and public sector pension funds, sovereign wealth funds, insurers, corporates, foundations, and central banks, as well as large retail financial groups, wealth managers, public and private equity as well as debt, private banks, and intermediaries. It seeks to invest in South African companies struggling with the economic fallout from the spread of coronavirus. The company was founded in 1991 and is headquartered in Cape Town, South Africa with additional offices in Africa, Americas, Asia-Pacific and Europe.

Full NINTF Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this NINTF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NINTF vs SCHDNINTF vs JEPININTF vs ONINTF vs KONINTF vs MAINNINTF vs ABBVNINTF vs MRKNINTF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.